Axon

Market Access
Market Access

Deep Dive: Market Access

For life science companies around the world, enabling faster access to innovative drugs and therapies is a complicated challenge.

R&D
Amplifying the voices in rare diseases

Amplifying the voices in rare diseases

There are approximately 300 million people around the world living with a rare disease. Yet, until relatively recently, there was limited focus on this heterogenous population.

Patients
Patients want to be heard. Is pharma listening?

Patients want to be heard. Is pharma listening?

A common theme heard from the advocacy groups AXON works with is “Nothing for us without us,” says Natalie Turner, director at AXON, a global healthcare communications agency.